Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia (Q44138790)

30 November 2017

Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia (English)

1 reference

30 November 2017

1 reference

4

Hélène Jacques

1 reference

30 November 2017

12

Jean Davignon

1 reference

30 November 2017

Jeffrey S Cohn

1

1 reference

30 November 2017

Michel Tremblay

2

1 reference

30 November 2017

Rami Batal

3

1 reference

30 November 2017

Lyne Veilleux

5

1 reference

30 November 2017

Claudia Rodriguez

6

1 reference

30 November 2017

P Hugh R Barrett

7

1 reference

30 November 2017

Denise Dubreuil

8

1 reference

30 November 2017

Madeleine Roy

9

1 reference

30 November 2017

Lise Bernier

10

1 reference

30 November 2017

Orval Mamer

11

1 reference

30 November 2017

1 September 2002

1 reference

Journal of Lipid Research

30 November 2017

1 reference

30 November 2017

43

1 reference

30 November 2017

9

1 reference

30 November 2017

1464-1471

1 reference

Apolipoprotein E mRNA is abundant in the brain and adrenals, as well as in the liver, and is present in other peripheral tissues of rats and marmosets

30 November 2017

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

From cholesterol transport to signal transduction: low density lipoprotein receptor, very low density lipoprotein receptor, and apolipoprotein E receptor-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Cyclic guanosine monophosphate as a mediator of vasodilation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Apolipoprotein E: from atherosclerosis to Alzheimer's disease and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Apolipoprotein E and atherosclerosis: insight from animal and human studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Apolipoprotein E and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Low levels of extrahepatic nonmacrophage ApoE inhibit atherosclerosis without correcting hypercholesterolemia in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Apolipoprotein E inhibits platelet aggregation through the L-arginine:nitric oxide pathway. Implications for vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Apolipoprotein E inhibition of proliferation of mitogen-activated T lymphocytes: production of interleukin 2 with reduced biological activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Statin therapy: where are we? Where do we go next?

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Atorvastatin. A review of its pharmacology and therapeutic potential in the management of hyperlipidaemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Abnormal in vivo metabolism of apolipoprotein E4 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Human triglyceride-rich lipoprotein apo E kinetics and its relationship to LDL apo B-100 metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Measurement of very low density and low density lipoprotein apolipoprotein (Apo) B-100 and high density lipoprotein Apo A-I production in human subjects using deuterated leucine. Effect of fasting and feeding

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

The APOE locus and the pharmacogenetics of lipid response

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

The effect of the HMG-CoA reductase inhibitor simvastatin and of cholestyramine on hepatic apolipoprotein mRNA levels in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Effect of simvastatin treatment on plasma apolipoproteins and hepatic apolipoprotein mRNA levels in the genetically hypercholesterolemic rat (RICO).

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Impaired secretion of very low density lipoprotein-triglycerides by apolipoprotein E- deficient mouse hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Overexpression and accumulation of apolipoprotein E as a cause of hypertriglyceridemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Proposal of a multicompartmental model for use in the study of apolipoprotein E metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Prevention of atherosclerosis in apolipoprotein E-deficient mice by bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Inhibition of ADP-induced platelet aggregation by apoE is not mediated by membrane cholesterol depletion

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Apolipoprotein E receptor binding versus heparan sulfate proteoglycan binding in its regulation of smooth muscle cell migration and proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Double-Blind Comparison of Apolipoprotein and Lipoprotein Particle Lowering Effects of Atorvastatin and Pravastatin Monotherapy in Patients With Primary Hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Type III hyperlipoproteinemia: defective metabolism of an abnormal apolipoprotein E

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Plasma catabolism of human apolipoprotein E isoproteins: lack of conversion of the doubly sialylated form to the asialo form in plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Familial HDL deficiency characterized by hypercatabolism of mature apoA-I but not proapoA-I

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Plasma concentration of apolipoprotein E in intermediate-sized remnant-like lipoproteins in normolipidemic and hyperlipidemic subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Effect of simvastatin on the synthesis and secretion of lipoproteins in relation to the metabolism of cholesterol in cultured hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Differential effects of lovastatin on the trafficking of endogenous and lipoprotein-derived cholesterol in human monocyte-derived macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Apolipoprotein E participates in the regulation of very low density lipoprotein-triglyceride secretion by the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

Overexpression of apolipoprotein E3 in transgenic rabbits causes combined hyperlipidemia by stimulating hepatic VLDL production and impairing VLDL lipolysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1194%2FJLR.M200016-JLR200

10.1194/JLR.M200016-JLR200

21 January 2018

Identifiers

DOI

1 reference

30 November 2017

1 reference